The widely expressed extracellular matrix protein SMOC-2 promotes keratinocyte attachment and migration

Experimental Cell Research

Volumn 314, Issue 13, 2008, Pages 2477-2487

  Maier, Silke ^a   Paulsson, Mats ^a,b   Hartmann, Ursula ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

BM 40; Calcium; Cell attachment; Cell migration; Extracellular matrix; Integrin; Osteonectin; SMOC; SPARC

Indexed keywords

CALCIUM BINDING PROTEIN; CELL RECEPTOR; INTEGRIN; OSTEONECTIN; SCLEROPROTEIN; SECRETED MODULAR CALCIUM BINDING PROTEIN 1; SECRETED MODULAR CALCIUM BINDING PROTEIN 2;

ANIMAL TISSUE; ARTICLE; CALCIUM BINDING; CELL ADHESION; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; EPIDERMIS; EPIDERMIS CELL; FOCAL ADHESION; HUMAN; HUMAN CELL; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN; TISSUE DISTRIBUTION;

EID: 47349116309     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.05.020     Document Type: Article

References (47)

1. Vannahme C., Gosling S., Paulsson M., Maurer P., and Hartmann U. Characterization of SMOC-2, a modular extracellular calcium-binding protein. Biochem. J. 373 (2003) 805-814
2. Vannahme C., Smyth N., Miosge N., Gosling S., Frie C., Paulsson M., Maurer P., and Hartmann U. Characterization of SMOC-1, a novel modular calcium-binding protein in basement membranes. J. Biol. Chem. 277 (2002) 37977-37986
3. Termine J.D., Kleinman H.K., Whitson S.W., Conn K.M., McGarvey M.L., and Martin G.R. Osteonectin, a bone-specific protein linking mineral to collagen. Cell 26 (1981) 99-105
4. Dziadek M., Paulsson M., Aumailley M., and Timpl R. Purification and tissue distribution of a small protein (BM-40) extracted from a basement membrane tumor. Eur. J. Biochem. 161 (1986) 455-464
5. Mann K., Deutzmann R., Paulsson M., and Timpl R. Solubilization of protein BM-40 from a basement membrane tumor with chelating agents and evidence for its identity with osteonectin and SPARC. FEBS Lett. 218 (1987) 167-172
6. Sage H., Johnson C., and Bornstein P. Characterization of a novel serum albumin-binding glycoprotein secreted by endothelial cells in culture. J. Biol. Chem. 259 (1984) 3993-4007
7. Maurer P., Hohenadl C., Hohenester E., Gohring W., Timpl R., and Engel J. The C-terminal portion of BM-40 (SPARC/osteonectin) is an autonomously folding and crystallisable domain that binds calcium and collagen IV. J. Mol. Biol. 253 (1995) 347-357
8. Mayer U., Aumailley M., Mann K., Timpl R., and Engel J. Calcium-dependent binding of basement membrane protein BM-40 (osteonectin, SPARC) to basement membrane collagen type IV. Eur. J. Biochem. 198 (1991) 141-150
9. Sasaki T., Gohring W., Mann K., Maurer P., Hohenester E., Knauper V., Murphy G., and Timpl R. Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens. J. Biol. Chem. 272 (1997) 9237-9243
10. Sasaki T., Hohenester E., Gohring W., and Timpl R. Crystal structure and mapping by site-directed mutagenesis of the collagen-binding epitope of an activated form of BM-40/SPARC/osteonectin. EMBO J. 17 (1998) 1625-1634
11. Bornstein P., and Sage E.H. Matricellular proteins: extracellular modulators of cell function. Curr. Opin. Cell. Biol. 14 (2002) 608-616
12. Raines E.W., Lane T.F., Iruela-Arispe M.L., Ross R., and Sage E.H. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 1281-1285
13. Kupprion C., Motamed K., and Sage E.H. SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. J. Biol. Chem. 273 (1998) 29635-29640
14. Lane T.F., and Sage E.H. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J. 8 (1994) 163-173
15. Murphy-Ullrich J.E., Lane T.F., Pallero M.A., and Sage E.H. SPARC mediates focal adhesion disassembly in endothelial cells through a follistatin-like region and the Ca(2+)-binding EF-hand. J. Cell Biochem. 57 (1995) 341-350
16. Funk S.E., and Sage E.H. The Ca2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 2648-2652
17. Bassuk J.A., Birkebak T., Rothmier J.D., Clark J.M., Bradshaw A., Muchowski P.J., Howe C.C., Clark J.I., and Sage E.H. Disruption of the Sparc locus in mice alters the differentiation of lenticular epithelial cells and leads to cataract formation. Exp. Eye Res. 68 (1999) 321-331
18. Hasselaar P., Loskutoff D.J., Sawdey M., and Sage E.H. SPARC induces the expression of typce 1 plasminogen activator inhibitor in cultured bovine aortic endothelial cells. J. Biol. Chem. 266 (1991) 13178-13184
19. Barker T.H., Baneyx G., Cardo-Vila M., Workman G.A., Weaver M., Menon P.M., Dedhar S., Rempel S.A., Arap W., Pasqualini R., Vogel V., and Sage E.H. SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity. J. Biol. Chem. 280 (2005) 36483-36493
20. Shi Q., Bao S., Song L., Wu Q., Bigner D.D., Hjelmeland A.B., and Rich J.N. Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases. Oncogene 26 (2007) 4084-4094
21. Sullivan M.M., Puolakkainen P.A., Barker T.H., Funk S.E., and Sage E.H. Altered tissue repair in hevin-null mice: inhibition of fibroblast migration by a matricellular SPARC homolog. Wound Repair Regen 16 (2008) 310-319
22. Sturm R.A., Satyamoorthy K., Meier F., Gardiner B.B., Smit D.J., Vaidya B., and Herlyn M. Osteonectin/SPARC induction by ectopic beta(3) integrin in human radial growth phase primary melanoma cells. Cancer Res. 62 (2002) 226-232
23. De S., Chen J., Narizhneva N.V., Heston W., Brainard J., Sage E.H., and Byzova T.V. Molecular pathway for cancer metastasis to bone. J. Biol. Chem. 278 (2003) 39044-39050
24. Gilmour D.T., Lyon G.J., Carlton M.B., Sanes J.R., Cunningham J.M., Anderson J.R., Hogan B.L., Evans M.J., and Colledge W.H. Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lens. EMBO J. 17 (1998) 1860-1870
25. Norose K., Clark J.I., Syed N.A., Basu A., Heber-Katz E., Sage E.H., and Howe C.C. SPARC deficiency leads to early-onset cataractogenesis. Invest. Ophthalmol. Vis. Sci. 39 (1998) 2674-2680
26. Delany A.M., Amling M., Priemel M., Howe C., Baron R., and Canalis E. Osteopenia and decreased bone formation in osteonectin-deficient mice. J. Clin. Invest. 105 (2000) 1325
27. Basu A., Kligman L.H., Samulewicz S.J., and Howe C.C. Impaired wound healing in mice deficient in a matricellular protein SPARC (osteonectin, BM-40). BMC Cell Biol. 2 (2001) 15
28. Bradshaw A.D., Reed M.J., and Sage E.H. SPARC-null mice exhibit accelerated cutaneous wound closure. J. Histochem. Cytochem. 50 (2002) 1-10
29. Lenarcic B., and Bevec T. Thyropins-new structurally related proteinase inhibitors. Biol. Chem. 379 (1998) 105-111
30. Molina F., Bouanani M., Pau B., and Granier C. Characterization of the type-1 repeat from thyroglobulin, a cysteine-rich module found in proteins from different families. Eur. J. Biochem. 240 (1996) 125-133
31. Shimasaki S., and Ling N. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog. Growth Factor Res. 3 (1991) 243-266
32. Nishimoto S., Hamajima Y., Toda Y., Toyoda H., Kitamura K., and Komurasaki T. Identification of a novel smooth muscle associated protein, smap2, upregulated during neointima formation in a rat carotid endarterectomy model. Biochim. Biophys. Acta. 1576 (2002) 225-230
33. Rocnik E.F., Liu P., Sato K., Walsh K., and Vaziri C. The novel SPARC family member SMOC-2 potentiates angiogenic growth factor activity. J. Biol. Chem. 281 (2006) 22855-22864
34. Liu P., Lu J., Cardoso W.V., and Vaziri C. The SPARC-related factor SMOC-2 promotes growth factor-induced cyclin D1 expression and DNA synthesis via integrin-linked kinase. Mol. Biol. Cell 19 (2008) 248-261
35. Kohfeldt E., Maurer P., Vannahme C., and Timpl R. Properties of the extracellular calcium binding module of the proteoglycan testican. FEBS Lett. 414 (1997) 557-561
36. Huang X., Wu J., Zhu W., Pytela R., and Sheppard D. Expression of the human integrin beta6 subunit in alveolar type II cells and bronchiolar epithelial cells reverses lung inflammation in beta6 knockout mice. Am. J. Respir. Cell Mol. Biol. 19 (1998) 636-642
37. Scherberich A., Tucker R.P., Degen M., Brown-Luedi M., Andres A.C., and Chiquet-Ehrismann R. Tenascin-W is found in malignant mammary tumors, promotes alpha8 integrin-dependent motility and requires p38MAPK activity for BMP-2 and TNF-alpha induced expression in vitro. Oncogene 24 (2005) 1525-1532
38. Becker C., Buttler P., and Graber H.G. Influence of anti-CD49f and anti-CD29 monoclonal antibodies on mitotic activity of epithelial cells (HaCaT) and gingival fibroblasts in vitro. Eur. J. Oral. Sci. 110 (2002) 137-143
39. Scharffetter-Kochanek K., Klein C.E., Heinen G., Mauch C., Schaefer T., Adelmann-Grill B.C., Goerz G., Fusenig N.E., Krieg T.M., and Plewig G. Migration of a human keratinocyte cell line (HACAT) to interstitial collagen type I is mediated by the alpha 2 beta 1-integrin receptor. J. Invest. Dermatol. 98 (1992) 3-11
40. Koivisto L., Larjava K., Hakkinen L., Uitto V.J., Heino J., and Larjava H. Different integrins mediate cell spreading, haptotaxis and lateral migration of HaCaT keratinocytes on fibronectin. Cell Adhes. Commun. 7 (1999) 245-257
41. Hintermann E., Bilban M., Sharabi A., and Quaranta V. Inhibitory role of alpha 6 beta 4-associated erbB-2 and phosphoinositide 3-kinase in keratinocyte haptotactic migration dependent on alpha 3 beta 1 integrin. J. Cell Biol. 153 (2001) 465-478
42. Girard J.P., and Springer T.A. Modulation of endothelial cell adhesion by hevin, an acidic protein associated with high endothelial venules. J. Biol. Chem. 271 (1996) 4511-4517
43. Lane T.F., and Sage E.H. Functional mapping of SPARC: peptides from two distinct Ca+(+)-binding sites modulate cell shape. J. Cell Biol. 111 (1990) 3065-3076
44. Busk M., Pytela R., and Sheppard D. Characterization of the integrin alpha v beta 6 as a fibronectin-binding protein. J. Biol. Chem. 267 (1992) 5790-5796
45. Marshall J.F., Rutherford D.C., McCartney A.C., Mitjans F., Goodman S.L., and Hart I.R. Alpha v beta 1 is a receptor for vitronectin and fibrinogen, and acts with alpha 5 beta 1 to mediate spreading on fibronectin. J. Cell Sci. 108 Pt 3 (1995) 1227-1238
46. Munger J.S., Huang X., Kawakatsu H., Griffiths M.J., Dalton S.L., Wu J., Pittet J.F., Kaminski N., Garat C., Matthay M.A., Rifkin D.B., and Sheppard D. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96 (1999) 319-328
47. Kraft S., Diefenbach B., Mehta R., Jonczyk A., Luckenbach G.A., and Goodman S.L. Definition of an unexpected ligand recognition motif for alphav beta6 integrin. J. Biol. Chem. 274 (1999) 1979-1985